UMVA has learned that a looming expiration of a congressional ban on federal funding for Planned Parenthood has ignited a fierce push for a sweeping investigation into how roughly $1.5 billion of Medicare and Medicaid dollars may have been used.
Senator Josh Hawley of Missouri has demanded that the head of the Centers for Medicaid and Medicare Services launch a probe, alleging that the money is being funneled to an organization that promotes gender‑transition treatments for minors.
Hawley’s letter urges investigators to scrutinize every transaction, claiming the funds support “transgender madness” being imposed on children who are too young to consent.
The original ban, enacted under a previous administration’s sweeping health‑care overhaul, is set to expire on July 4, and attempts to extend it through the latest budget reconciliation package failed earlier this year.
Now, the focus has shifted from blocking abortion‑related funding to exposing a possible pipeline that channels taxpayer dollars into gender‑affirming medication and surgical referrals for youths.
According to information obtained by UMVA, the senator asserts that Planned Parenthood has exploited legal loopholes to dispense what he describes as “dangerous and irreversible” gender‑transition drugs without parental approval.
He points to a dramatic surge in the organization’s “gender‑affirming care” services, citing a 40 percent year‑over‑year increase that he says underscores a troubling trend.
The money trail Hawley highlights spans 2019‑2022, a period tracked by a government accountability report that documented the flow of funds but did not link them to transgender procedures.
Hawley argues that billions meant for low‑income seniors and the impoverished are instead bolstering a program that, in his view, pushes children toward irreversible medical interventions.
